Hitchwood Capital Management’s Guardant Health GH Stock Holding History

Hitchwood Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-320,000	Closed	-$32M	–	32
2021 Q4	$32M	Hold	320,000	–	–	1.08%	29
2021 Q3	$40M	Hold	320,000	–	–	1.16%	31
2021 Q2	$39.7M	Hold	320,000	–	–	0.73%	31
2021 Q1	$48.8M	Sell	320,000 -30,000	-9%	-$4.53M	1.11%	28
2020 Q4	$45.1M	Buy	350,000 +50,000	+17%	+$5.75M	0.77%	31
2020 Q3	$33.5M	Buy	300,000 +25,000	+9%	+$2.29M	0.89%	31
2020 Q2	$22.3M	Buy	275,000 +145,000	+112%	+$11.7M	1.04%	32
2020 Q1	$9.05M	Sell	130,000 -100,000	-43%	-$7.67M	0.74%	31
2019 Q4	$18M	Sell	230,000 -170,000	-43%	-$12.3M	0.43%	45
2019 Q3	$25.5M	Sell	400,000 -195,000	-33%	-$17.2M	1.17%	33
2019 Q2	$51.4M	Buy	595,000 +465,000	+358%	+$35.5M	0.88%	26
2019 Q1	$9.97M	Buy	+130,000	New	+$7.21M	0.14%	49

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Hitchwood Capital Management's GH Position: Q1 2022 in Review

Hitchwood Capital Management sold out of Guardant Health (GH) in Q1 2022, closing a stake of 320,000 shares — an estimated $32M sold.

Hitchwood Capital Management first reported a position in GH in Q1 2019 and held it in 12 quarters. The position peaked at $51.4M in Q2 2019. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

Hitchwood Capital Management reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
Hitchwood Capital Management sold 320,000 Guardant Health shares in Q1 2022, an estimated $32M.
Hitchwood Capital Management first reported a position in Guardant Health in Q1 2019 and held it in 12 quarters.
Hitchwood Capital Management's Guardant Health position peaked at $51.4M in Q2 2019.
356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Hitchwood Capital Management's 13F filing for Q1 2022, filed 16 May 2022.